JAK2 and essential thrombocythemia: In regards to diagnosis, PV is expected to be almost always accompanied by a JAK2 mutation, whereas the specific driver mutation cannot otherwise distinguish one MPN from another; however, in distinguishing ET from pre-PMF or mPV, a higher JAK2V617F allele burden favors the diagnoses of the latter rather than the former.